SpringerLink
Log in

The Correlation Between Intestinal Gonadotropin-Releasing Hormone (GnRH) and Proglucagon in Hyperlipidemic Rats and Goto-Kakizaki (GK) Rats

  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Our experiment investigated the mRNA expression of intestinal gonadotropin-releasing hormone (GnRH), proglucagon (PG), and glucagon-like peptide 1 receptor (GLP-1R) in the jejunum, ileum, and colon of rats fed with high-fat diet and Goto-Kakizaki (GK) rats and revealed the physiological role of intestinal GnRH. We found that the GnRH and PG mRNA levels in high-cholesterol (HCh) diet were higher than in the control. However, the GnRH receptor (GnRHR) and GLP-1R mRNA levels did not differ significantly between HCh and control. The GnRH, PG, and GLP-1R mRNA levels in GK rats were lower, respectively, than those in control rats, while the GnRHR levels did not differ significantly between GK rats and control rats. There were no difference in GnRH, PG, GnRHR, and GLP-1R mRNA levels in the ileum and colon tissue between HCh and control rats. The GnRH mRNA levels of GK rats were lower than those in control rats; however, the PG, GLP-1R, and GnRHR levels did not differ significantly between GK and control rats. The GLP-1R mRNA levels of GK rats were lower than those in control rats. The GnRH mRNA expression showed positive correlation with PG mRNA expression in different intestinal sections. The GnRH level in the jejunum showed a significant effect on blood glucose level, while the PG level in the jejunum showed a significant effect on insulin level. This may imply that, compared with the ileum and colon, the jejunum had greater impact on glucose metabolism; furthermore, GnRH might interact with intestinal GLP-1 and GLP-2 through the paracrine and autocrine ways and then regulate glucose metabolism and insulin secretion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Moore B, Eille ES, Abram JH. On the treatment of diabetes mellitus by acid extract of duodenal mucous membrane. Biochem J 1:28–38, 1906.

    CAS  PubMed  Google Scholar 

  2. Nauck MA, Homberger E, Siegel EG, Allen RC, Eaton RP, Ebert R, Creutzfeldt W. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab 63:492–8, 1986.

    Article  CAS  PubMed  Google Scholar 

  3. Nauck MA, Stockmann F, Ebert R, Creutzfeldt W. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 29:46–52, 1986.

    Article  CAS  PubMed  Google Scholar 

  4. Adachi T, Tanaka T, Takemoto K, Koshimizn TA, Hirasawa A, Tsujimoto G. Free fatty acids administered into the colon promote the secretion of glucagons-like peptide-1 and insulin. Biochem Biophys Res Commun 340:332–7, 2006.

    Article  CAS  PubMed  Google Scholar 

  5. Partriti A, Facchiano E, Annetti C, Aisa MC, Galli F, Fanelli C, Donini A. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg 15:1258–64, 2005.

    Article  Google Scholar 

  6. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 239:1–11, 2004.

    Article  PubMed  Google Scholar 

  7. Rubino F, Forgione A, Cummings D, Vix M, Gnuli D, Mingrone G, Castagneto M, Marescaux J. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the roximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244:741–9, 2006.

    Article  PubMed  Google Scholar 

  8. Laferrère B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, Kovack B, Bawa B, Koshy N, Lee H, Yapp K, Olivan B. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 93:2479–85, 2008.

    Article  PubMed  Google Scholar 

  9. Huang QW, Zhang ZL. Study of distribution on GnRH immunity activity cell and nerves in gastroenteropancreatic system. Acta Anatomica Sinica 21:20–30, 1990.

    Google Scholar 

  10. Huang QW, **ang ZH, Meng L. Study of distribution on GnRH mRNA-positive epithelial cells and nerve cells in rat gastroenteropancreatic system. Acta Anatomica Sinica 27:35–7, 1996.

    Google Scholar 

  11. Huang QW, Yao B, Sun L, Pu RL, Wang L, Zhang RQ. Immunohistochemical and in situ hybridization of gonadotropin releasing hormone (GnRH) and its receptor in rat digestive tract. Life Sci 68:1727–34, 2001.

    Article  CAS  PubMed  Google Scholar 

  12. Yao B, Huang QW, Pu RL, Sun L. In situ hybridization study of gonadotropin releasing hormone receptor mRNA in rat digestive tract. Acta Anatomica Sinica 31:248–52, 2000.

    Google Scholar 

  13. Yao B, Huang W, Huang Y, Chui Y, Wang Y, Li H, Pu R, Wan L, Zhang R. A study on the localization and distribution of GnRH and its receptor in rat. Life Sci 72:2895–904, 2003.

    Article  CAS  PubMed  Google Scholar 

  14. Gao B, Ji QH, Huang WQ. Immunohistochemical localization of glucagon, gonadotropin releasing hormone receptor in rat digestive tract. Chinese Journal of Anatomy 27:372–9, 2004.

    Google Scholar 

  15. Smith MR. Osteoporosis and obesity in men receiving hormone therapy for prostate cancer. J Urol 172:S52–6, 2004.

    Article  PubMed  Google Scholar 

  16. Smith MR, Lee H, Nathan DM. Insulin sensitivity during combined androgen blockade for prostate cancer. J Clin Endocrinol Metab 91:1305–8, 2006.

    Article  CAS  PubMed  Google Scholar 

  17. Palomba S, Russo T, Orio Jr F, Sammartino A, Sbano FM, Nappi C, Colao A, Mastrantonio P, Lombardi G, Zullo F. Lipid, glucose and lomocysteine metabolism in women treated with a GnRH agonist with or without raloxifene. Hum Reprod 19:415–21, 2004.

    Article  CAS  PubMed  Google Scholar 

  18. Tietz NW. Textbook of clinical chemistry. New York: Saunders; 1986.

    Google Scholar 

  19. Mello de Mello MA, de Souza CT, Braga LR, dos Santos JW, Ribeiro IA, Gobatto CA. Glucose tolerance and insulin action in monosodium glutamate (MSG) obese exercise-trained rats. Physiol Chem Phys Med NMR 33:63–71, 2001.

    Google Scholar 

  20. Portha B. Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm. Diabetes Metab Res Rev 21:495–504, 2005.

    Article  CAS  PubMed  Google Scholar 

  21. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 87: 1409–39, 2007.

    Article  CAS  PubMed  Google Scholar 

  22. Gautier JF, Fetita S, Sobngwi E, Salaun-Martin C. Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes. Diabetes Metab 31:233–42, 2005.

    Article  CAS  PubMed  Google Scholar 

  23. Bojanowska E. Physiology and pathophysiology of glucagon-like peptide-1 (GLP-1): the role of GLP-1 in the pathogenesis of diabetes mellitus, obesity, and stress. Med Sci Monit 11:RA271–8, 2005.

    CAS  PubMed  Google Scholar 

  24. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM, Lynis D. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339–50, 1995.

    Article  CAS  PubMed  Google Scholar 

  25. Pories WJ, Albrecht RJ. Etiology of type II diabetes mellitus: role of the foregut. World J Surg 25:527–31, 2001.

    Article  CAS  PubMed  Google Scholar 

  26. Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 236:554–9, 2002.

    Article  PubMed  Google Scholar 

  27. Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care 31: S290–6, 2008.

    Article  PubMed  Google Scholar 

  28. Ansari MA, Dhar M, Spieker S. Modulation of diabetes with gonadotropin-releasing hormone antagonists in the nonobese mouse model of autoimmune diabetes. Endocrinology 145:337–42, 2004.

    Article  CAS  PubMed  Google Scholar 

  29. Klier M, Schusdziarra V, Pfeiffer EF. Effect of luteinizing hormone-releasing hormone upon insulin release from rat islets in vitro. FEBS Lett 121:363–4, 1980.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant of the National Natural Science Foundation of China (30870948) “Eleventh five-year plan AIDS and viral hepatitis prevention and treatment of infectious diseases and other major special major science and technology”—Early-Warning System for Tuberculosis (no. 2008ZX100(03-008)) and Investigation on Methodology for Estimation and Prediction of HIV/AIDS Epidemic (no. 2008ZX10100(01-003)).

Conflict of interest statement

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Endocrinology, ****g Hospital, The Fourth Military Medical University, **’an, China

    Li Wang, Hongwei Cao, Rong Chen, Nanyan Zhang, Jianfang Fu, Bin Gao, **g Zhang, Rongrong Hou & Qiuhe Ji

  2. The Research Center of Bioinformatics, School of Life Science and Technology, **’an Jiaotong University, **’an, China

    **g Wu

  3. Department of Burns, ****g Hospital, The Fourth Military Medical University, **’an, China

    Chaowu Tang

Authors
  1. Li Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. **g Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hongwei Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rong Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nanyan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jianfang Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bin Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. **g Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Rongrong Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Chaowu Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Qiuhe Ji
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qiuhe Ji.

Additional information

Li Wang and **g Wu equally contributed to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, L., Wu, J., Cao, H. et al. The Correlation Between Intestinal Gonadotropin-Releasing Hormone (GnRH) and Proglucagon in Hyperlipidemic Rats and Goto-Kakizaki (GK) Rats. Endocr Pathol 20, 227–234 (2009). https://doi.org/10.1007/s12022-009-9086-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-009-9086-y

Keywords

Search

Navigation